期刊文献+

两种介入手术方案对多支病变冠心病患者围术期临床指标、生存率及术后并发症发生率的影响 被引量:4

Effects of two kinds of interventional operation scheme on perioperative clinical indicators, survival rate and postoperative complications incidence of patients with multivessel coronary artery disease
下载PDF
导出
摘要 目的探讨非体外循环冠状动脉旁路移植术与一站式复合冠状动脉血运重建术对多支病变冠状动脉粥样硬化性心脏病(冠心病)患者围术期临床指标、生存率及术后并发症发生率的影响。方法研究对象选取青岛阜外心血管病医院2007年3月至2011年7月收治的多支病变冠心病患者共110例,其中,行非体外循环冠状动脉旁路移植术共82例设为对照组,行一站式复合冠状动脉血运重建术共28例设为观察组。比较两组围术期临床指标、随访3年生存率及术后并发症发生率等。结果观察组术中输血率、呼吸机辅助时间、术后胸腔积液量、重症监护病房停留时间及住院时间均显著优于对照组,差异有统计学意义(P<0.05)。两组随访期间生存率比较,差异无统计学意义(P>0.05)。两组术后并发症发生率比较,差异无统计学意义(P>0.05)。结论非体外循环冠状动脉旁路移植术与一站式复合冠状动脉血运重建术对多支病变冠心病具有接近的临床疗效及安全性;同时,一站式复合冠状动脉血运重建术可有效减少术中创伤,缩短呼吸机使用时间,并有助于加快病情康复进程。 Objective To investigate the effects of two kinds of interventional operation scheme including off-pump coronary artery bypass graftine (CABG) and one-step hybrid coronary revascularization on perioperative clinical indicators, survival rate and postoperative complications incidence of patients with multivessel coronary artery disease. Methods Totally 110 patients with muhivessel coronary artery disease from March 2007 to July 2011 in Qingdao Fuwai Cardiovascular Hospital were chosen and divided into two groups, including control group (82 cases) with offpump CABG and observation group (28 cases) with one-step hybrid coronary revascularization. Levels of perioperative clinical indicators, survival rates in 3 years with follow-up and postoperative complication incidences of both groups were compared. Results Blood transfusion rate during operation and postoperative pleural effusion volume of observation grooup were significanly lower than those of control group (P〈0.05). And ventilation time, intensive-care-unit- staying-duration and inhospital-staying-duration of obsevation group were significantly shorter than those of control group (P〈0.05). There was no significant difference in the survival rate during follow-up between the 2 groups (P〉 0.05). There was no significant difference in postoperative complication incidence between the 2 groups (P〈0.05). Conclusions Off-pump CABG and one-step hybrid coronary revascularization in treatment of patients with muhivessel coronary artery disease possess the same clinical effects and safety; but one-step hybrid coronary revascularization application can effectively reduce the trauma degree during operation, shorten the time of respirator being used and be helpful to shorten the rehabilitation process.
出处 《岭南心血管病杂志》 2016年第5期520-522,548,共4页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 非体外循环冠状动脉旁路移植术 一站式复合冠状动脉血运重建术 冠状动脉多支病变 coronary artery disease off-pump coronary artery bypassgrofting one-step hybrid coronaryrevascularization multivessel coronary artery disease
  • 相关文献

参考文献15

  • 1HU SS, LI Q, GA0 P X, et al. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease [J]. Ann Thorae Surg, 2011, 91 (3) : 432-439.
  • 2王浩然,胡盛寿,徐波,李立环,熊辉.“一站式”复合技术治疗冠状动脉多支病变患者早中期随访结果[J].中国胸心血管外科临床杂志,2012,19(3):232-234. 被引量:3
  • 3MARIZIA L, JOHN G B, NATALIA S, et al. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE[J]. J Thorac Cardiovasc Surg, 2012, 22(4) : 1-9.
  • 4PALMERINI T, GENEREUX P, CAIXETA A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention [J]. J Am Coil Cardiol, 2011, 57(4): 2389-2397.
  • 5HALKOS M E, VASSILIADES T A, DOUGLAS J S, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of muhivessel coronary artery disease [J]. Ann Thorac Surg, 2011, 92 (5) : 1695- 1702.
  • 6ROBERT A B, ADNAN K, KLAUS T, et al. 2-year clinical and angiographic outcomes from a randomized trial of polymer- free dual drug-eluting stents versus polymer-based cypher and endeavor, drug-eluting stents[J]. J Am Coil Cardiol 2010, 55 (3) : 2536-2543.
  • 7刘美慧,吴延庆,龚韧,张洪洲,程晓曙.应用Endo-PAT评价经桡动脉途径介入术后外周血管内皮功能的变化[J].实用医学杂志,2015,31(4):562-564. 被引量:5
  • 8JULINDA M, ROBERT A B, KLAUS T, et al. Randomized trial of paclitaxel-versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents [J]. J Am Coil Cardiol, 2010, 55(4): 2710-2716.
  • 9KIM Y H, PARK D W, LEE J Y, et al. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease[J]. Circulation, 2011, 123(5): 2373-2381.
  • 10DAGENAIS G R, LU J, FAXON D P, et al. Effects of optimal medical treatment with or without coronary revaseularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stabie ischemic heart disease[J]. Circulation, 2011, 123(7) : 1492-1500.

二级参考文献47

  • 1王芳,王梅,王海燕.动脉粥样硬化患者肾动脉狭窄患病率的调查[J].中华肾脏病杂志,2005,21(3):139-142. 被引量:66
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2009:274.
  • 3The BARI investigators. Influence of diabetes on 5-year mortalityand morbidity in a randomized trial comparing CABG and PTCAin patients with multivessel disease : the Bypass AngioplastyRevascularization Investigation (BARI). Circulation, 1997, 96:1761-1769.
  • 4Jeremias A, Kaul S, Rosengart TK, et al. The impact ofrevascularization on mortality in patients with nonacute coronaryartery disease. Am J Med, 2009, 122:152-161.
  • 5Katritsis DG,Ioannidis JP. Percutaneous coronary interventionversus conservative therapy in nonacute coronary artery disease: ameta-analysis. Circulation, 2005,111 : 2906-2912.
  • 6Schomig A,Mehilli J, De Waha A, et al. A meta-analysis of 17randomized trials of a percutaneous coronary intervention-basedstrategy in patients with stable coronary artery disease. J Am CollCaixliol, 2008, 52: 894-904.
  • 7Trikalinos TA,Alsheikh-Ali AA, Tatsioni A, et al. Percutaneouscoronary interventions for non-acute coronary artery disease ; aquantitative 20-year synopsis and a network meta-analysis.Lancet, 2009, 373:911-918.
  • 8Boden WE, O' Rourke RA,Teo KK, et al. Optimal medicaltherapy with or without PCI for stable coronary disease. N Engl JMed, 2007,356: 1503-1516.
  • 9Dagenais GR,Lu J, Faxon DP, et al. Effects of optimal medicaltreatment with or without coronary revascularization on angina andsubsequent revascularizations in patients with type 2 diabetesmellitus and stable ischemic heart disease. Circulation, 2011,123:1492-1500.
  • 10Kim YH,Park DW, Lee JY, et al. Impact of angiographiccomplete revascularization after drug-eluting stent implantation orcoronary artery bypass graft surgery for multivessel coronary arterydisease. Circulation, 2011, 123:2373-2381.

共引文献16

同被引文献30

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部